Articles tagged with Drug Combinations
A study suggests that frequent dental visits can eliminate gingival overgrowth recurrence in patients taking nifedipine for high blood pressure. This regimen significantly reduces gum swelling and associated health risks.
Patients with fibromyalgia syndrome experience significant improvements in physical condition, symptom reports, and mental state when using non-drug treatments like exercise and cognitive behavioral therapy. Non-drug techniques were found to be superior to medication alone in reducing symptoms and improving daily functioning.
Research finds that revival in AIDS patients brings new uncertainties, affecting feelings of hope and future orientation, social roles and identities, interpersonal relationships, and changes in quality of life.
A University of Florida study found that in two-thirds of the 44 children treated, T cell numbers increased to normal levels. Children under 6 showed the most pronounced improvement, with their immune systems recovering dramatically.
A new study by Case Western Reserve University researchers found that relaxation and music can significantly reduce post-operative pain in surgery patients. The study, which tested 500 patients over a 29-month period, showed that these self-care methods reduced pain more than medication alone.
A study of over 1,000 older, disabled women reveals that nearly two-thirds report significant pain in multiple areas, yet many use inadequate or ineffective doses of medication. This mismatch suggests a need for better pain management strategies among older adults.
A combination of nefazodone and psychotherapy is more effective than either medication or therapy alone in treating chronic depression, with an 85% response rate. The study also found significant improvement in insomnia and early symptom reduction.
A survey of nearly 1,000 primary care providers found that those with more experience were more likely to recommend evidence-based treatments for HIV. The study suggests that patients with HIV should have access to experienced physicians who can provide high-quality care.
A UPMC study of 124 depressed elderly participants found that a combination of medication and psychotherapy prevented depression recurrence in 80 percent of patients, while medication alone was effective in only 57 percent. The study suggests that continued treatment can significantly reduce the risk of recurrence.
Researchers found that brief angiostatin exposure is sufficient to enhance the effects of radiation therapy. The combination of angiostatin and radiation resulted in significantly smaller tumors compared to other treatment groups.
Penn physicians developed clinical guidelines for herbal therapies, emphasizing the importance of understanding herbal agents' properties and potential risks. The guidelines caution against using certain herbal products, especially those with toxic effects, and recommend discussing risks and benefits with patients.
The Massachusetts General Hospital is leading a five-year, $20 million research study to improve the diagnosis and treatment of bipolar disorder. The study aims to evaluate existing treatment protocols and test new medications for the condition.
Women who develop diabetes during pregnancy face an increased risk of later developing type-2 diabetes. Using the mini-pill, progestin-only birth control pills, may put these women at a higher risk of developing chronic form of the disease, warns USC researchers.
A study by UCSF found that many HIV-positive injection drug users are not receiving protease inhibitors despite their availability, with 21% unaware of their status and only 14% still taking the medication. Common obstacles include homelessness, fear, and lack of access to healthcare services.
Researchers found that non-dermatologists prescribed less-effective yet more costly medications for fungal skin diseases. Dermatologists prescribed single agents with lower failure rates and costs. The study has implications for health maintenance organizations limiting access to specialists.
The updated guidelines advocate for early, potent combination antiretroviral therapies to prevent AIDS in individuals infected with HIV. The new recommendations suggest that simpler drug regimens may offer greater compliance and convenience.
Case reports reveal four patients died or went into shock after switching from mibefradil to other calcium channel blockers, highlighting the dangerous interaction between the two drugs. The risk is attributed to mibefradil's long half-life and its ability to inhibit liver enzymes that metabolize other medications.
A study of 574 Americans and 250 Canadians found that only a small fraction received appropriate depression treatment, with more Canadians receiving mental health services due to comprehensive national coverage. Patient attitudes, such as perception of need for help and fear of cost, also played a significant role in the disparity.
Phase II data reveals amprenavir's potent drug profile, with sustained antiviral effects seen in patients treated with two-drug combinations. The medication is currently being evaluated in pivotal Phase III clinical trials and has an expected US new drug application filing later in 1998.
The new guidelines, JNC VI, recommend stratifying patients into risk groups based on blood pressure stage and presence of risk factors. Lifestyle changes are advised for all patients on drug therapy, regardless of risk group.
A new test developed by Johns Hopkins researchers uses white blood cells to predict which medications are most effective for each patient with kidney disease. The study found a wide range of responses among patients, suggesting that such tests might assist physicians in developing personalized treatment strategies.
Researchers found synergy in two strains of Enterococcus faecalis when combining trovafloxacin and ampicillin/sulbactam, but not in other tested strains. Combination antibiotic treatment remains the only effective means to eliminate vancomycin-resistant enterococcal infections.
A recent study published in The New England Journal of Medicine found that a diet rich in fruits, vegetables, and low-fat dairy products can significantly lower blood pressure. Among participants with high-normal or stage 1-mild hypertension, the DASH combination diet reduced systolic and diastolic blood pressure by an average of 3.5 m...
A study published in Neurology has identified long-term exposure to copper and manganese as a significant risk factor for developing Parkinson's disease. The study found that occupational exposure to these metals, either alone or in combination with other metals like lead and iron, increased the risk of acquiring the disease.
People with idiopathic anaphylaxis experience unpredictable, life-threatening symptoms without an external cause. Prompt diagnosis and preventive therapy with a combination of prednisone, hydroxyzine, and albuterol are critical to prevent death.
A recent NIH study found that a combination of a protease inhibitor and two nucleoside analogue reverse transcriptase inhibitors can significantly reduce the occurrence of AIDS-defining illnesses or death. The study, ACTG 320, demonstrated improved survival and delayed disease progression in patients receiving triple combination therapy.
A diet high in fruits, vegetables, low-fat dairy products and other low-fat foods significantly lowers blood pressure, according to a multicenter study. The combination diet reduced systolic blood pressure by an average of 5.5 mm Hg and diastolic pressure by an average of 3.0 mm Hg within two weeks.
Two NIH-supported studies show that lifestyle modifications, such as a low-fat, high-fiber diet, can substantially reduce blood pressure in adults. The findings also suggest that weight loss and reduced dietary sodium can safely reduce the need for antihypertensive medication in older patients.
A new hormonal drug combination allows post-menopausal women to get the benefits of estrogen without experiencing menses-like bleeding. The therapy significantly increases bone mineral density and improves blood cholesterol levels.
The FDA has approved fexofenadine, a new antihistamine that effectively relieves seasonal allergy symptoms without the risk of fatal heart conditions. Developed by Georgetown pharmacologist Raymond Woosley, fexofenadine was discovered through research on Seldane's cardiac side effects.